BIOR
Biora Therapeutics, Inc.
Set alert
0.22 USD 0.00 0.00%
0.22 Day range 0.22
0.26 52-week range 19.90
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.22
- Prev close
- 0.22
- Mkt cap
- 2.04M
- Vol
- 169.45K
- Avg vol
- 132.00K
- EPS
- 0.36
- P/E
- 1.25
- Div yield
- 0.00%
More statistics
- Low
- 0.22
- High
- 0.22
- Forward P/E
- -0.04
- Beta
- 0.00
- Short ratio
- 2.37
- Inst. own
- 36.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 2.44
- 200-d avg
- 5.90
- 1y target
- 34.00
Financial health
Altman Z-Score
-109.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.2×
FY 2018 5y median -11.3× FY 2023
P/S 5323×
FY 2018 5y median 82.4× FY 2023
P/B -0.2×
FY 2018 5y median -2.4× FY 2023
P/FCF -0.4×
FY 2018 5y median -1.2× FY 2023
EV/EBITDA -0.5×
FY 2018 5y median -3.3× FY 2023
EV/Sales 13377×
FY 2018 5y median 192× FY 2023
FCF Yield -228.2%
FY 2018 5y median -83.8% FY 2023
Profitability
Gross Margin 100.0%
FY 2018 5y median 100.0% FY 2023
Operating Margin -1678575.0%
FY 2018 5y median -9449.6% FY 2023
Net Margin -3102875.0%
FY 2018 5y median -12510.5% FY 2023
ROE 122.4%
FY 2018 5y median 176.5% FY 2023
ROIC 232.3%
FY 2018 5y median -196.9% FY 2023
ROA -397.6%
FY 2018 5y median -145.5% FY 2023
Growth (YoY)
Revenue -98.7%
FY 2018 FY 2023
Operating Income -8.7%
FY 2018 FY 2023
EPS (diluted) -1129.7%
FY 2018 FY 2023
Free Cash Flow 25.5%
FY 2018 FY 2023
Financial Health
Current Ratio 0.3×
FY 2018 5y median 1.6× FY 2023
Quick Ratio 0.3×
FY 2018 5y median 1.6× FY 2023
Debt / Equity -0.5×
FY 2018 5y median -1.3× FY 2023
Net Debt / EBITDA -0.3×
FY 2018 5y median -0.3× FY 2023
Interest Coverage -6.8×
FY 2018 5y median -9.3× FY 2023
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-12-31